Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103


Testing the effect of early-life reproductive effort on age-related decline in a wild insect.

Rodríguez-Muñoz R, Boonekamp JJ, Liu XP, Skicko I, Fisher DN, Hopwood P, Tregenza T.

Evolution. 2019 Feb;73(2):317-328. doi: 10.1111/evo.13679. Epub 2019 Jan 10.


Comparing individual and population measures of senescence across 10 years in a wild insect population.

Rodríguez-Muñoz R, Boonekamp JJ, Liu XP, Skicko I, Haugland Pedersen S, Fisher DN, Hopwood P, Tregenza T.

Evolution. 2019 Feb;73(2):293-302. doi: 10.1111/evo.13674. Epub 2019 Jan 10.


Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial.

Bhattacharya IS, Haviland JS, Kirby AM, Kirwan CC, Hopwood P, Yarnold JR, Bliss JM, Coles CE; IMPORT Trialists.

J Clin Oncol. 2019 Feb 1;37(4):305-317. doi: 10.1200/JCO.18.00982. Epub 2018 Dec 11.


New challenges in psycho-oncology: An embodied approach to body image.

Hopwood P, Hopwood N.

Psychooncology. 2019 Feb;28(2):211-218. doi: 10.1002/pon.4936. Epub 2018 Nov 29. No abstract available.


Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer.

Mills J, Haviland JS, Moynihan C, Bliss JM, Hopwood P; START Trial Management Group.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):433-441. doi: 10.1016/j.clon.2018.03.007. Epub 2018 Apr 10.


Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.


Reply to Goodare et al. Re: Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy?

Haviland J, Yarnold J, Bliss J, Hopwood P, Wilcox M.

Clin Oncol (R Coll Radiol). 2016 Oct;28(10):665-6. doi: 10.1016/j.clon.2016.07.008. Epub 2016 Jul 28. No abstract available.


Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Haviland JS, Hopwood P, Mills J, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Clin Oncol (R Coll Radiol). 2016 Jun;28(6):345-53. doi: 10.1016/j.clon.2016.01.011. Epub 2016 Feb 8.


Learning from the QUEST multicentre feasibility randomization trials in breast reconstruction after mastectomy.

Winters ZE, Emson M, Griffin C, Mills J, Hopwood P, Bidad N, MacDonald L, Turton EP, Horne R, Bliss JM; QUEST Trial Management Group; QUEST Trial Management Group.

Br J Surg. 2015 Jan;102(1):45-56. doi: 10.1002/bjs.9690.


Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001).

Hall E, Cameron D, Waters R, Barrett-Lee P, Ellis P, Russell S, Bliss JM, Hopwood P; TACT Trial Investigators.

Eur J Cancer. 2014 Sep;50(14):2375-89. doi: 10.1016/j.ejca.2014.06.007. Epub 2014 Jul 24.


The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.


The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses.

Campbell HE, Epstein D, Bloomfield D, Griffin S, Manca A, Yarnold J, Bliss J, Johnson L, Earl H, Poole C, Hiller L, Dunn J, Hopwood P, Barrett-Lee P, Ellis P, Cameron D, Harris AL, Gray AM, Sculpher MJ.

Eur J Cancer. 2011 Nov;47(17):2517-30. doi: 10.1016/j.ejca.2011.06.019. Epub 2011 Jul 7.


Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.

Challberg J, Ashcroft L, Lalloo F, Eckersley B, Clayton R, Hopwood P, Selby P, Howell A, Evans DG.

Br J Cancer. 2011 Jun 28;105(1):22-7. doi: 10.1038/bjc.2011.202. Epub 2011 Jun 7.


Absence of markers of betaretrovirus infection in human pulmonary adenocarcinoma.

Hopwood P, Wallace WA, Cousens C, Dewar P, Muldoon M, Norval M, Griffiths DJ.

Hum Pathol. 2010 Nov;41(11):1631-40. doi: 10.1016/j.humpath.2010.05.013. Epub 2010 Sep 9.


Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.

Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, Yarnold JR; START Trial Management Group.

Lancet Oncol. 2010 Mar;11(3):231-40. doi: 10.1016/S1470-2045(09)70382-1. Epub 2010 Feb 6.


The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START).

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM; START Trials Management Group.

Breast. 2010 Apr;19(2):84-91. doi: 10.1016/j.breast.2009.11.007. Epub 2009 Dec 29.


The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, Kennedy J, Howell A, Wardley AM, Radford JA.

Br J Cancer. 2009 Aug 18;101(4):582-8. doi: 10.1038/sj.bjc.6605215.


Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24. doi: 10.1158/1055-9965.EPI-09-0171.


Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.

Ellis P, Barrett-Lee P, Johnson L, Cameron D, Wardley A, O'Reilly S, Verrill M, Smith I, Yarnold J, Coleman R, Earl H, Canney P, Twelves C, Poole C, Bloomfield D, Hopwood P, Johnston S, Dowsett M, Bartlett JM, Ellis I, Peckitt C, Hall E, Bliss JM; TACT Trial Management Group; TACT Trialists.

Lancet. 2009 May 16;373(9676):1681-92. doi: 10.1016/S0140-6736(09)60740-6.


Health-related quality of life assessment after breast reconstruction.

Potter S, Thomson HJ, Greenwood RJ, Hopwood P, Winters ZE.

Br J Surg. 2009 Jun;96(6):613-20. doi: 10.1002/bjs.6605.


Supplemental Content

Loading ...
Support Center